The latest report by IMARC Group, titled "United States Point of Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End User, and Region, 2026-2034", offers a comprehensive analysis of the industry, which comprises insights on the United States point of care diagnostics market. The report also includes competitor and regional analysis.
United States Point of Care Diagnostics Market Size Overview and Growth Forecast (2026–2034)
The United States point of care diagnostics market size reached USD 14.0 Billion in 2025 and is expected to grow to USD 25.2 Billion by 2034, registering a CAGR of 6.43% during 2026–2034. Market growth is supported by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and decentralized diagnostic testing, and growing adoption of home-based and self-testing solutions. As healthcare providers continue to prioritize faster clinical decision-making and improved patient outcomes, the United States point of care diagnostics market growth is expected to remain steady over the forecast period.
Key Market Statistics at a Glance
Base Year: 2025
Historical Years: 2020–2025
Forecast Period: 2026–2034
Market Size (2025): USD 14.0 Billion
Projected Size (2034): USD 25.2 Billion
Growth Rate: CAGR of 6.43%
Explore Growth Opportunities in the United States Point of Care Diagnostics Market Grab Your Sample Report for Evaluation:https://www.imarcgroup.com/united-states-point-of-care-diagnostics-market/requestsample
Key Factors Driving the United States Point of Care Diagnostics Market
Growing demand for rapid, accurate, and decentralized diagnostic testing is one of the major factors supporting the United States point of care diagnostics market growth. Healthcare providers are increasingly adopting compact, easy-to-use testing platforms that deliver quick results at or near the site of patient care, reducing turnaround time and improving treatment decisions. The expansion of home healthcare, telemedicine, and retail clinics is also helping broaden access to point of care testing. In addition, rising prevalence of chronic conditions such as diabetes and cardiovascular disease, along with continued technological innovation in biosensors and portable diagnostic devices, continues to strengthen the United States point of care diagnostics market share across different testing categories.
United States Point of Care Diagnostics Market Segmentation and Industry Trends
The United States point of care diagnostics market analysis covers multiple product categories, platforms, prescription modes, and end-user segments. Infectious disease testing and glucose monitoring continue to represent key segments, while cardiac markers, pregnancy and fertility testing, and coagulation testing are also witnessing healthy demand. Among the leading United States point of care diagnostics market trends are the growing popularity of connected and digitally integrated testing devices, increasing use of over-the-counter self-testing kits, and higher demand for multiplexed diagnostic platforms. These trends are encouraging manufacturers to expand their product portfolios and invest in product innovation.
Challenges and Opportunities in the United States Point of Care Diagnostics Market
The market faces challenges such as stringent regulatory approval requirements, reimbursement uncertainties, and concerns regarding test accuracy compared to centralized laboratory testing. However, these factors are encouraging companies to improve quality control and focus on validated, high-performance products. There are also significant opportunities for companies offering connected devices, multiplex testing panels, and home-based diagnostic solutions. As consumer and provider preferences continue to evolve, businesses investing in innovation, digital health integration, and regulatory compliance are well positioned to benefit from the continued United States point of care diagnostics market growth.
Future Outlook: What's Next for the United States Point of Care Diagnostics Market?
The outlook for the United States point of care diagnostics market remains positive, supported by product innovation, digital health transformation, and changing patient care models. Future United States point of care diagnostics market trends are expected to include greater adoption of AI-assisted diagnostic platforms, expanded home and self-testing solutions, and stronger integration with electronic health records. Companies that focus on innovation, accuracy, and strong provider engagement will be well placed to expand their United States point of care diagnostics market share and capitalize on long-term growth opportunities through 2034.
United States Point of Care Diagnostics Market Segmentation:
Product Type Insights:
- Glucose Testing
- Infectious Disease Testing
- Cardiac Markers Testing
- Pregnancy and Fertility Testing
- Coagulation Testing
- Hematology Testing
- Cholesterol/Lipid Testing
- Drug of Abuse Testing
- Cancer Marker Testing
- Others
Platform Insights:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Others
Prescription Mode Insights:
- Prescription-Based Testing
- Over-the-Counter (OTC) Testing
End User Insights:
- Hospitals and Clinics
- Physician Office Laboratories
- Home Care Settings and Self-Testing
- Urgent Care and Retail Clinics
- Others
Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=20479&flag=C
Major Players Shaping the United States Point of Care Diagnostics Market
- Abbott Laboratories – A leading diagnostics company offering a wide portfolio of point of care testing platforms, including glucose monitoring, infectious disease, and cardiac testing solutions.
- Hoffmann-La Roche Ltd. – Focuses on advanced diagnostic technologies and rapid testing platforms, with a strong presence across hospital and clinical testing segments.
- Siemens Healthineers – Provides a broad range of point of care diagnostic instruments and consumables, supported by continuous innovation and strong regulatory compliance.
- Danaher Corporation – Offers point of care testing solutions through its diagnostics businesses, with a focus on molecular and infectious disease testing.
- QuidelOrtho Corporation – Specializes in rapid diagnostic testing solutions, including infectious disease and cardiac marker testing, supported by an expanding product pipeline.
- Becton, Dickinson and Company (BD) – Manufactures a wide range of diagnostic and testing products, emphasizing quality, accuracy, and clinical reliability.
Author IMARC Group
IMARC Group is a leading global management consulting firm providing comprehensive market research, feasibility studies, and strategic advisory services. The firm supports organizations worldwide in identifying growth opportunities, mitigating risks, and making informed business decisions across industries.
Contact Us
IMARC Group
Email: sales@imarcgroup.com
United States: +1-201-971-6302